Anita Brikman/thefemword.world
Jul 21, 2026, 00:55
Anita Brikman on PPTA’s First-Half 2026 Achievements
Plasma Protein Therapeutics Association (PPTA) shared on LinkedIn:
”As 2026 reaches its midpoint, PPTA and its members have made significant progress in strengthening patient access to plasma-derived therapies worldwide.
From advancing advocacy efforts in North America and Europe to expanding global stakeholder engagement and supporting important regulatory initiatives, the first half of the year has demonstrated the power of collaboration across the plasma community.
Watch as PPTA President and CEO Anita Brikman reflects on key achievements from the first six months of 2026, then read the full report.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe LippiÖ‰ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question